Samsung investing big in biopharmaceuticals, AI, chips, robotics

SEOUL (Reuters) -Samsung Group will invest 240 trillion won ($206 billion) in the next three years to expand its footprint in biopharmaceuticals, artificial intelligence, semiconductors and robotics in the post-pandemic era, Samsung Electronics Co Ltd said. Samsung Electronics, the world’s largest memory chip maker, said the group plans to solidify technology and market leadership through mergers and acquisitions. Samsung Group has 59 affiliates with assets totalling 457 trillion won, according to South Korea’s Fair Trade Commission. The investment plan comes just over a week since Samsung Group leader Jay Y. Lee was released from jail on parole following convictions for bribery and embezzlement. ($1 = 1,167.0800 won)(Reporting by Heekyong Yang, Editing by Sherry Jacob-Phillips and Christopher Cushing)Related article: Samsung sees strong chip demand and mobile recovery, profits jump

Read Full Article Here

If You Like This Story, Support NYOOOZ



Your support to NYOOOZ will help us to continue create and publish news for and from smaller cities, which also need equal voice as much as citizens living in bigger cities have through mainstream media organizations.

Related Articles